Evaxion Biotech A/S Adr (EVAX) has released an update.
Evaxion Biotech A/S has announced its annual general meeting scheduled for April 16, 2024, encouraging shareholders to participate in critical decisions such as the election of the board members, approval of the financial report, and authorization for the board to issue new warrants. Key proposals include re-electing the current board and authorizing the board to increase the company’s share capital to strengthen its financial footing. The meeting will also cover the adoption of the annual report and the management’s plan to carry forward the previous year’s loss.
For further insights into EVAX stock, check out TipRanks’ Stock Analysis page.
